Comprehensive Genomic Profiling of 274 Thymic Epithelial Tumors Unveils Oncogenic Pathways and Predictive Biomarkers

por Girard, Nicolas, Basse, Clémence, Schrock, Alexa, Ramkissoon, Shakti, Killian, Keith, Ross, Jeffrey S
Publicado 2022

Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss

por Bou Zerdan, Maroun, Ashok Kumar, Prashanth, Haroun, Elio, Srivastava, Nimisha, Ross, Jeffrey, Sivapiragasam, Abirami
Publicado 2023

Addendum: Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss

por Bou Zerdan, Maroun, Ashok Kumar, Prashanth, Haroun, Elio, Srivastava, Nimisha, Ross, Jeffrey, Sivapiragasam, Abirami
Publicado 2023

Comparing two assays for clinical genomic profiling: the devil is in the data

por Squillace, Rachel M, Frampton, Garrett M, Stephens, Phil J, Ross, Jeffrey S, Miller, Vincent A
Publicado 2015

Analysis of MDM2 Amplification: Next-Generation Sequencing of Patients With Diverse Malignancies

por Kato, Shumei, Ross, Jeffrey S., Gay, Laurie, Dayyani, Farshid, Roszik, Jason, Subbiah, Vivek, Kurzrock, Razelle
Publicado 2018

Unique Genomic Landscape of High-Grade Neuroendocrine Cervical Carcinoma: Implications for Rethinking Current Treatment Paradigms

por Eskander, Ramez N., Elvin, Julia, Gay, Laurie, Ross, Jeffrey S., Miller, Vincent A., Kurzrock, Razelle
Publicado 2020

Molecular Targets in Salivary Gland Cancers: A Comprehensive Genomic Analysis of 118 Mucoepidermoid Carcinoma Tumors

por Bou Zerdan, Maroun, Kumar, Prashanth Ashok, Zaccarini, Daniel, Ross, Jeffrey, Huang, Richard, Sivapiragasam, Abirami
Publicado 2023

Comprehensive Landscape of Cyclin Pathway Gene Alterations and Co-occurrence with FGF/FGFR Aberrations Across Urinary Tract Tumors

por Jardim, Denis L F, Millis, Sherri Z, Ross, Jeffrey S, Lippman, Scott, Ali, Siraj M, Kurzrock, Razelle
Publicado 2022

Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large‐Scale Data to Inform Therapeutic Directions

por Jardim, Denis L., Millis, Sherri Z., Ross, Jeffrey S., Woo, Michelle Sue‐Ann, Ali, Siraj M., Kurzrock, Razelle
Publicado 2020

Landscape of Cyclin Pathway Genomic Alterations Across 5,356 Prostate Cancers: Implications for Targeted Therapeutics

por Jardim, Denis L., Millis, Sherri Z., Ross, Jeffrey S., Woo, Michelle Sue‐Ann, Ali, Siraj M., Kurzrock, Razelle
Publicado 2021

A Combination of Targeted Therapy with Chemotherapy Backbone Induces Response in a Treatment-Resistant Triple-Negative MCL1-Amplified Metastatic Breast Cancer Patient

por Ali, Siraj M., Watson, Jessica, Wang, Kai, Chung, Jon H., McMahon, Caitlin, Ross, Jeffrey S., Dicke, Karel A.
Publicado 2016

Proteomic Assessment of Biochemical Pathways That Are Critical to Nickel-Induced Toxicity Responses in Human Epithelial Cells

por Ge, Yue, Bruno, Maribel, Haykal-Coates, Najwa, Wallace, Kathleen, Andrews, Debora, Swank, Adam, Winnik, Witold, Ross, Jeffrey A.
Publicado 2016

Phosphatidylinositol 3‐kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities

por Millis, Sherri Z., Jardim, Denis L., Albacker, Lee, Ross, Jeffrey S., Miller, Vincent A., Ali, Siraj M., Kurzrock, Razelle
Publicado 2018

Real-World Comprehensive Genomic Profiling Success Rates in Tissue and Liquid Prostate Carcinoma Specimens

por Hiemenz, Matthew C, Graf, Ryon P, Schiavone, Kelsie, Harries, Lukas, Oxnard, Geoffrey R, Ross, Jeffrey S, Huang, Richard S P
Publicado 2022

N of 1 case reports of exceptional responders accrued from pancreatic cancer patients enrolled in first-in-man studies from 2002 through 2012

por Garrido-Laguna, Ignacio, Tometich, Danielle, Hu, Nan, Ying, Jian, Geiersbach, Katherine, Whisenant, Jonathan, Wang, Kai, Ross, Jeffrey S., Sharma, Sunil
Publicado 2015

VV-ECMO for surgical cure of a critical central airway obstruction

por Raza, Hassan A., Nokes, Brandon T., Jaroszewski, Dawn, Garrett, Ashley, Sista, Ramachandra, Ross, Jeffrey, Farmer, Joseph C., Lyng, Philip J.
Publicado 2019

Comparison of PD-L1 tumor cell expression with 22C3, 28-8, and SP142 IHC assays across multiple tumor types

por Maule, Jake G, Clinton, Lani K, Graf, Ryon P, Xiao, Jinpeng, Oxnard, Geoffrey R, Ross, Jeffrey S, Huang, Richard S P
Publicado 2022

Real-world Validation of TMB and Microsatellite Instability as Predictive Biomarkers of Immune Checkpoint Inhibitor Effectiveness in Advanced Gastroesophageal Cancer

por Graf, Ryon P., Fisher, Virginia, Creeden, James, Schrock, Alexa B., Ross, Jeffrey S., Nimeiri, Halla, Oxnard, Geoffrey R., Klempner, Samuel J.
Publicado 2022

Comprehensive genomic profiling identifies novel NTRK fusions in neuroendocrine tumors

por Sigal, Darren S., Bhangoo, Munveer S., Hermel, Jonathan A., Pavlick, Dean C., Frampton, Garrett, Miller, Vincent A., Ross, Jeffrey S., Ali, Siraj M.
Publicado 2018

Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon

por Natarajan, Thanemozhi G, Kallakury, Bhaskar V, Sheehan, Christine E, Bartlett, Margaret B, Ganesan, Natarajan, Preet, Anju, Ross, Jeffrey S, FitzGerald, Kevin T
Publicado 2010